U.S Pharmaceutical Third-Party Logistics Services Market Growth, Size, Trends Analysis- By Product Type, By Temperature, By Therapeutic Area, By Manufacturer Size- Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

U.S Pharmaceutical Third-Party Logistics Services Market Introduction and Overview

According to SPER market research, 'U.S Pharmaceutical Third-Party Logistics Services Market Size- By Product Type, By Temperature, By Therapeutic Area, By Manufacturer Size- Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the U.S Pharmaceutical Third-Party Logistics Services Market is predicted to reach 109.76 billion by 2034 with a CAGR of 9.15%.

Specialized supply chain solutions designed for the pharmaceutical and healthcare sectors are referred to as pharmaceutical third-party logistics (3PL) services. These services cover cold chain logistics, inventory control, warehousing, packing, and shipping of medications and medical supplies that are sensitive to temperature changes. 3PL suppliers offer real-time tracking and visibility across the supply chain and guarantee adherence to strict regulatory standards, including GDP (Good Distribution Practices).

Restraints: The effectiveness and compliance of pharmaceutical third-party logistics (3PL) services can be affected by a number of issues. Keeping temperature-sensitive items intact throughout the supply chain is a significant challenge, particularly when shipping them internationally or across long distances. Operations become more difficult when strict rules like GDP, FDA, and other regional criteria must be followed.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product Type, By Temperature, By Therapeutic Area, By Manufacture Size

Regions covered

Northeast, Midwest, West, South

Companies Covered

Cardinal Health, Cencora Corporation (ICS), CEVA Logistics, DB SCHENKER, EVERSANA, Kerry Logistics Network Limited, Knipper Health, Kuehne+Nagel, McKesson Corporation, Thermo Fisher Scientific.

U.S Pharmaceutical Third-Party Logistics Services Market Segmentation:

By Product Type: Based on the Product Type, U.S Pharmaceutical Third-Party Logistics Services Market is segmented as; Branded, Generic, Biosimilar, Vaccine, Cell Therapy, Gene Therapy, Others.

By Temperature: Based on the Temperature, U.S Pharmaceutical Third-Party Logistics Services Market is Segmented as; Ambient, Refrigerated, Frozen, Ultra-Frozen/Deep Frozen, Cryogenic.

By Therapeutic Area: Based on the Therapeutic Area, U.S Pharmaceutical Third-Party Logistics Services Market is Segmented as; Oncology, Cardiovascular Diseases, Infectious Diseases, Neurology, Diabetes, Nephrology, Rheumatology, Asthma, Others.

By Manufacturer Size: Based on the Manufacture Size, U.S Pharmaceutical Third-Party Logistics Services Market is Segmented as; Large, Medium, Small.

By Region: This research also includes data Northeast, Midwest, West, South

Product Code: HLCA25246

1.Introduction

1.1.Scope of the report
1.2.Market segment analysis

2.Research Methodology

2.1.Research data source
- 2.1.1.Secondary Data
- 2.1.2.Primary Data
- 2.1.3.SPERs internal database
- 2.1.4.Premium insight from KOLs
2.2.Market size estimation
- 2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation

3.Executive Summary

4.Market Dynamics

4.1.Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1.Drivers
- 4.1.2.Restraints
- 4.1.3.Opportunities
- 4.1.4.Challenges

5.Market variable and outlook

5.1.SWOT Analysis
- 5.1.1.Strengths
- 5.1.2.Weaknesses
- 5.1.3.Opportunities
- 5.1.4.Threats
5.2.PESTEL Analysis
- 5.2.1.Political Landscape
- 5.2.2.Economic Landscape
- 5.2.3.Social Landscape
- 5.2.4.Technological Landscape
- 5.2.5.Environmental Landscape
- 5.2.6.Legal Landscape
5.3.PORTERs Five Forces
- 5.3.1.Bargaining power of suppliers
- 5.3.2.Bargaining power of buyers
- 5.3.3.Threat of Substitute
- 5.3.4.Threat of new entrant
- 5.3.5.Competitive rivalry
5.4.Heat Map Analysis

6.Competitive Landscape

6.1.U.S Pharmaceutical Third-Party Logistics Services Market Manufacturing Base Distribution, Sales Area, Temperature Therapeutic Area
6.2.Mergers & Acquisitions, Partnerships, Temperature Launch, and Collaboration in U.S Pharmaceutical Third-Party Logistics Services Market

7.U.S Pharmaceutical Third-Party Logistics Services Market, By Product Type 2021-2034 (USD Million)

7.1.Branded
7.2.Generic
7.3.Biosimilar
7.4.Vaccine
7.5.Cell Therapy
7.6.Gene Therapy
7.7.Others

8.U.S Pharmaceutical Third-Party Logistics Services Market, By Temperature 2021-2034 (USD Million)

8.1.Ambient
8.2.Refrigerated
8.3.Frozen
8.4.Ultra-Frozen/Deep-Frozen
8.5.Cryogenic

9.U.S Pharmaceutical Third-Party Logistics Services Market, By Therapeutic Area 2021-2034 (USD Million)

9.1.Oncology
9.2.Cardiovascular Diseases
9.3.Infectious Diseases
9.4.Neurology
9.5.Diabetes
9.6.Nephrology
9.7.Rheumatology
9.8.Asthma
9.9.Others

10. U.S Pharmaceutical Third-Party Logistics Services Market, By Manufacturer Size 2021-2034 (USD Million)

10.1.Large
10.2.Medium
10.3.Small

11.U.S Pharmaceutical Third-Party Logistics services Market, 2021-2034 (USD Million)

11.1.U.S Pharmaceutical Third-Party Logistics services Market Size and Market Share

12.U.S Pharmaceutical Third-Party Logistics services Market, By Region, 2021-2034 (USD Million)

12.1.Northeast
12.2.Midwest
12.3.West
12.4.South

13.Company Profile

13.1.Cardinal Health
- 13.1.1.Company details
- 13.1.2.Financial outlook
- 13.1.3.Temperature summary
- 13.1.4.Recent developments
13.2.Cencora Corporation (ICS)
- 13.2.1.Company details
- 13.2.2.Financial outlook
- 13.2.3.Temperature summary
- 13.2.4.Recent developments
13.3.CEVA Logistics
- 13.3.1.Company details
- 13.3.2.Financial outlook
- 13.3.3.Temperature summary
- 13.3.4.Recent developments
13.4.DB SCHENKER
- 13.4.1.Company details
- 13.4.2.Financial outlook
- 13.4.3.Temperature summary
- 13.4.4.Recent developments
13.5.EVERSANA
- 13.5.1.Company details
- 13.5.2.Financial outlook
- 13.5.3.Temperature summary
- 13.5.4.Recent developments
13.6.Kerry Logistics Network Limited
- 13.6.1.Company details
- 13.6.2.Financial outlook
- 13.6.3.Temperature summary
- 13.6.4.Recent developments
13.7.Knipper Health
- 13.7.1.Company details
- 13.7.2.Financial outlook
- 13.7.3.Temperature summary
- 13.7.4.Recent developments
13.8.Kuehne+Nagel
- 13.8.1.Company details
- 13.8.2.Financial outlook
- 13.8.3.Temperature summary
- 13.8.4.Recent developments
13.9.McKesson Corporation
- 13.9.1.Company details
- 13.9.2.Financial outlook
- 13.9.3.Temperature summary
- 13.9.4.Recent developments
13.10.Thermo Fisher Scientific
- 13.10.1.Company details
- 13.10.2.Financial outlook
- 13.10.3.Temperature summary
- 13.10.4.Recent developments
13.11.Others